Public Company News
Baby Shark Teams Up with the London Symphony Orchestra for a 10-Year Celebration
* Set for worldwide release on September 19, featuring a new digital single
and a complete vinyl album expanded with an additional track
* Special collaboration with the world-renowned London Symphony Orchestra
Download image here
2025-09-18 21:00
2091
WiMi Researches a Quantum Machine Learning Framework for Enhanced Privacy Protection
BEIJING, Sept. 18, 2025 /PRNewswire/ -- WiMi Hologram Cloud Inc. (NASDAQ: WiMi) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, today announced that they are committed to developing a hybrid quantum-classical model that combines the acceleration ...
2025-09-18 21:00
1655
EPWK Launches Global Platform, Sets Sights on Becoming a Creative Services Infrastructure Company
XIAMEN, China, Sept. 18, 2025 /PRNewswire/ -- EPWK (NASDAQ: EPWK), the first
Chinese AI-powered creative services platform to go public in the U.S., has
officially launched its international siteintl.epwk.com
2025-09-18 20:00
1534
SK Networks successfully hosts "SK Networks AI WAVE 2025" as part of its ongoing commitment to expanding the AI Ecosystem
- Under the theme 'Pitch the Future and Connect the Dots', the event brought together leadingAI startups and investors - The event showcased SK Networks' key AI portfolio companies, including Upstage and PhnyX Lab - A panel discussion on the future of Sovereign AI featured SK Networks' President ...
2025-09-18 20:00
2063
JinkoSolar Announces Completion of Sale of A Shares in Its Subsidiary, Jinko Solar Co., Ltd., through Inquiry Transfer and Placement
SHANGRAO, China, Sept. 18, 2025 /PRNewswire/ -- JinkoSolar Holding Co., Ltd. (" JinkoSolar" or the "Company") (NYSE: JKS), one of the largest and most innovative solar module manufacturers in the world, today announced that the Company has completed the sale of 300,156,075 A shares of Jinko Solar ...
2025-09-18 18:51
2315
iHuman Inc. Announces Second Quarter 2025 Unaudited Financial Results
BEIJING, Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH) ("iHuman" or the "Company"), a leading provider of tech-powered, intellectual development products inChina, today announced its unaudited financial results for the second quarter endedJune 30, 2025. Second Quarter 2025 Highlights ...
2025-09-18 16:30
4229
iHuman and Cricket Media Team Up to Launch Reading Stars
Reading Stars seamlessly merges Cricket's award-winning content with iHuman's cutting-edge technology, creating an entirely new way for children to engage with reading. BEIJING and MCLEAN, Va., Sept. 18, 2025 /PRNewswire/ -- iHuman Inc. (NYSE: IH), a leading provider of tech‑powered, intellectua...
2025-09-18 16:00
1376
Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2)
SAN FRANCISCO and SUZHOU, China, Sept. 18, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabol...
2025-09-18 12:00
1756
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway
Meaningful improvements confirmed in slow-progressor subgroup; biomarker reductions support precision-medicine approach and potential FDA accelerated pathway SEOUL, South Korea, Sept. 17, 2025 /PRNewswire/ -- CorestemChemon Inc. (KOSDAQ: 166480) announced today that it has presented key findings...
2025-09-18 10:28
1915
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025
SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announces that the updated long-term follow-up results of Phase I clinical trial of zevorcabtagene autoleucel (zevor-cel, R&D code...
2025-09-18 08:15
2089
NAVER CEO Choi Soo-yeon Appointed to UN Global Compact Board of Directors, Strengthening International Partnerships for "AI Governance"
- CEO Choi recognized for her leadership in global dialogues and cooperation to advance safe AI development and establish a digital ecosystem - Sanda Ojiambo, CEO and Executive Director of the UN Global Compact, said, "CEOChoi Soo-yeon's global leadership and deep expertise will be a great asset ...
2025-09-18 08:00
2048
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025
--Denifanstat (ASC40) met all primary, key secondary and secondary efficacy endpoints (ITT analysis) and significantly improved moderate-to-severe acne compared with placebo. --Denifanstat (ASC40) demonstrated a favorable safety and tolerability profile. Treatment emergent adverse events (TEAEs)...
2025-09-18 07:30
1700
Xiao-I Corporation Renews Strategic Partnership with Leading Global Bank to Elevate Digital Banking Experience
SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- Xiao-I Corporation (NASDAQ: AIXI), a global leader in artificial intelligence solutions, today announced the successful renewal of its strategic partnership with one of the world's premier financial institutions, a multinational banking organization renown...
2025-09-17 21:45
2412
Cheche Group Expands Partnership with Volkswagen Anhui, Delivering End-to-End Risk Management for New Energy Vehicles
BEIJING, Sept. 17, 2025 /PRNewswire/ -- Cheche Group Inc.
2025-09-17 20:30
4130
Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders
SHANGHAI and OAKLAND, Calif., Sept. 17, 2025 /PRNewswire/ -- Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) and Aditum Bio today announced the launch of Kalexo Bio, a new company formed in conjunction with an exclusive global license agreement to develop2MW7141, a novel dual-target siRNA cand...
2025-09-17 20:00
1492
Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9)
* EYLUXVI® is the second biosimilar approved for Alteogen following the launch of the Herceptin® biosimilar in China through its partner Qilu Pharmaceutical. DAEJEON, South Korea, Sept. 17, 2025 /PRNewswire/ -- Alteogen Inc. (KOSDAQ:196170) announced today that the European Commission (EC) has ...
2025-09-17 15:40
1990
111, Inc. Announces Second Quarter 2025 Unaudited Financial Results
* Maintained Quarterly Operational Profitability * Operating Expenses as a Percentage of Revenues Decreased 20 Basis Points YoY * Maintained Positive Operating Cash Flow in the First Half of the Year SHANGHAI, Sept. 17, 2025 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a l...
2025-09-17 14:00
4383
Three WuXi Biologics Manufacturing Facilities Receive GMP Certification from Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK)
WUXI, China, Sept. 17, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced that three of its manufacturing facilities in Wuxi – MFG1, MFG2, and DP5 – have received GMP certification from Türkiye İlaç ve ...
2025-09-17 12:00
1682
Kexing Biopharm's Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Registered with FDA DMF
SHENZHEN, China, Sept. 16, 2025 /PRNewswire/ -- Kexing Biopharm announced that its investigational Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes has successfully completed a Type II Drug Master File (DMF) registration with the U.S. FDA. Exosomes, as a next-generation bioactive carr...
2025-09-17 10:30
1309
Ascletis Presented Results from Cohorts 1 and 2 of 28-day Multiple Ascending Dose Study of Its Oral Small Molecule GLP-1R Agonist ASC30 at the 61st European Association for the Study of Diabetes (EASD) Annual Meeting
- ASC30 once-daily oral tablet demonstrated up to 6.5% placebo-adjusted mean body weight reduction from baseline after 28-day treatment. - ASC30 tablet's higher efficacy is supported by its higher oral drug exposures. - ASC30 is safe and well tolerated with only mild-...
2025-09-17 07:30
1579
Week's Top Stories
Most Reposted
One Universal Production Group (OUP) Officially Opens, Reinforcing Its Position as Asia's Leading IP Ecosystem and Tourism Company
[Picked up by 313 media titles]
2025-12-20 09:36
Singapore Airshow 2026 Marks 10th Edition with New Frontiers in Aviation and Space
[Picked up by 309 media titles]
2025-12-18 19:41
Nine Years of Impact: JULO Disburses USD 1.7 Billion in Digital Financing Across Indonesia
[Picked up by 294 media titles]
2025-12-23 14:23
foodpanda Strengthens Merchant Care with Record Onboarding Milestone in Asia
[Picked up by 292 media titles]
2025-12-18 17:15Commanding Accolades: Peach Blossoms and Executive Chinese Chef Edward Chong Honoured by Multiple International Award Wins
[Picked up by 288 media titles]
2025-12-18 17:43
Most Read
Cognizant and Microsoft Expand Partnership to Advance AI Transformation and Frontier Firm Experiences
2025-12-18 22:00
6738
Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year 2026 Financial Results
2025-12-20 05:05
5997